Professor Center for iPS Cell and Research and Application (CiRA), Kyoto University Kyoto, Kyoto, Japan
Disclosure(s):
Shin Kaneko, MD, PhD: No relevant disclosure to display
Learning Objectives:
Upon completion, participant will be able to understand how human T cells are regenerated through induced pluripotent stem cells.
Upon completion, participant will be able to understand how iPSC-derived T cells are genetically modified as a clinical product for allogeneic immunotherapy.
Upon completion, participant will be able to understand how iPSC-derived T cells are thought to be used for controlling immunological hyperactivity.
